Health

  • October 02, 2025

    AstraZeneca Asks Judge To Block Colorado's 340B Drug Law

    AstraZeneca urged a Colorado federal judge on Wednesday to block the enforcement of a recently enacted state law that aims to extend a federal drug discount program to certain pharmacies, saying the Colorado law is costly for manufacturers and preempted by federal law.

  • October 02, 2025

    Fed. Circ. Affirms Cutting $10M Med Device IP Verdict To $1

    The Federal Circuit on Thursday said a lower court had properly reduced to $1 what had been a $10 million patent infringement verdict against Intuitive Surgical Inc., saying any amount between the two figures "would require improper guesswork," given the lack of evidence on damages.

  • October 02, 2025

    Ill. Panel Backs Whistleblower's $3.5M Retaliation Verdict

    An Illinois appellate panel on Wednesday affirmed a $3.5 million verdict for a man who claimed he was unlawfully fired from a southern Illinois hospital system for reporting Medicare and Medicaid fraud and abuse, saying jurors saw evidence he and others faced retaliation when they "called attention to what they believed to be unlawful conduct." 

  • October 02, 2025

    Ill. Panel Rejects Challenge To Abortion Coverage Mandate

    Illinois' mandate that health policies issued in the state cover abortion care does not violate an Illinois religious freedom law, a state appeals court ruled, rejecting a Baptist organization's claims that the mandate "substantially burdened" its religious beliefs per the Illinois Religious Freedom Restoration Act.

  • October 02, 2025

    Mass. Court Denies States' Bid To Block ACA Subsidy Cuts

    A Massachusetts federal court has rejected a bid by a coalition of 21 states to stay implementation of a rule that will cut Affordable Care Act subsidies and enforce enrollment restrictions, saying the states hadn't shown imminent or irreparable harm from the policy's costs or possible coverage losses.

  • October 02, 2025

    Healthcare AI Co. Says Biz Partner Holding IP 'Hostage'

    A company creating artificial intelligence-powered tools meant for skin image analysis has alleged in Massachusetts federal court that another firm it entered into a business deal with was holding data and intellectual property "hostage" after its CEO ordered his staff to cease a planned data migration.

  • October 02, 2025

    Many Cos. Not Ready For National Security Risks, Report Says

    At least a third of U.S. companies aren't fully prepared to address key national security compliance risks they face, and the C-suite often isn't aligned with its in-house counsel as to who is primarily responsible for those efforts, according to a new survey from Eversheds Sutherland.

  • October 02, 2025

    Justices To Hear Clash Over State Med Mal Laws In Fed. Court

    The U.S. Supreme Court is scheduled to hear oral arguments Monday on whether a Delaware medical malpractice statute can be applied in federal court, in a case that is expected to offer legal guidelines for similar laws in 28 other states.

  • October 02, 2025

    Ex-Firm Can't Revive Malicious Prosecution Suit In 11th Circ.

    The Eleventh Circuit has refused to overturn lower court rulings nixing a malicious prosecution lawsuit brought by a now-defunct law firm against a surgical center, as well as a sanctions ruling against the firm's counsel.

  • October 02, 2025

    Singaporean Biotech To Go Public Via $1.5B SPAC Merger

    Singapore-based biotechnology company Nanyang Biologics Pte. Ltd. on Thursday announced plans to go public in the U.S. by merging with special purpose acquisition company RF Acquisition Corp. II in a deal that gives the biotech a pre-transaction equity value of $1.5 billion.

  • October 02, 2025

    Agency Ex-Exec Says He Was Misled About CEO Agreement

    A former executive at a company providing assistance to people with intellectual disabilities and autism claimed in a lawsuit that he was misled over whether he was officially promoted, even as the company held him out to state regulators and banks as the chief executive officer.

  • October 02, 2025

    UChicago Medicine Ducks Class Claims In Patient Privacy Suit

    A UChicago Medicine patient can move forward with amended privacy violation claims over the medical center's allegedly illegal use of Meta pixel tracking tools but must leave her class allegations behind, given an agreement she entered between pleadings, an Illinois federal judge ruled.

  • October 02, 2025

    Cravath, Kirkland Lead Berkshire's $9.7B OxyChem Buy

    Warren Buffett's Berkshire Hathaway is set to acquire energy giant Occidental's chemical business, OxyChem, in a $9.7 billion all-cash megadeal built by Cravath Swaine & Moore LLP and Kirkland & Ellis LLP.

  • October 01, 2025

    Pa. Court Affirms 53-Year Sentence In Baby's Drug Death

    A woman sentenced to up to 53 years in prison for the fentanyl-related murder of her newborn was rightfully convicted, the Pennsylvania Superior Court said Wednesday, finding that via her breast milk or by other means she undoubtedly contributed to her child's demise because drugs were all over her home.

  • October 01, 2025

    Eli Lilly's Drug Suit Slammed As 'Anti-Competitive' Move

    Eli Lilly and Co.'s lawsuit accusing a compounding pharmacy of unlawfully selling untested weight loss drugs should be tossed because the drugmaker didn't show its advertising was deceptive or harmful, the defendant told a Texas federal court this week.

  • October 01, 2025

    Ga. Panel Revives Injury Suit Alleging IV Mixup Against Emory

    The Georgia Court of Appeals on Wednesday revived a woman's lawsuit against a group of registered nurses and Emory Healthcare Inc., in which she alleged her left hand had to be amputated after she was given medication through an IV line there instead of a larger vein.

  • October 01, 2025

    Medtronic Knocks Out Investor Suit Over Insulin Pump Issues

    Medical device manufacturer Medtronic PLC has escaped proposed investor class action claims it concealed issues affecting a certain insulin pump it makes, hurting investors after its trading prices fell when the company disclosed it had received a related warning letter from the U.S. Food and Drug Administration.

  • October 01, 2025

    DHS Accused Of Illegal Data Use In Voter Purge Lawsuit

    The League of Women Voters and a group of naturalized U.S. citizens are suing to stop the Trump administration's pooling of immigrant personal data across federal agencies into centralized databases at the U.S. Department of Homeland Security, saying states are using the "unreliable" systems to purge voter rolls.

  • October 01, 2025

    Texas Judge Sends Mifepristone Challenge To Missouri Court

    A closely watched challenge to federal approvals for the abortion medication mifepristone is moving from Texas to Missouri after a federal judge found the plaintiffs remaining in the litigation have no connection to the Lone Star State.

  • October 01, 2025

    Trans Athlete Fights To Halt High Court Review Of Idaho Ban

    Lindsay Hecox told the U.S. Supreme Court on Tuesday her case challenging an Idaho state law banning transgender athletes such as herself is now moot because she has dropped her litigation, providing "no basis" to proceed with a review, contrary to the state's arguments saying otherwise.

  • October 01, 2025

    3rd Circ. Hints Forum Query Premature In $139M Award Row

    A Third Circuit panel wondered Wednesday whether a Delaware court asked the right question before it concluded that it lacked jurisdiction over a Chilean company's quest to rope an Italian contractor's U.S. assets into a bid to collect on a $139 million arbitration award.

  • October 01, 2025

    Ga. Atty DQ'd From 'Extremely Weird' Pharma Fraud Case

    A Georgia federal judge said Wednesday she intends to disqualify a prominent defense attorney from representing a man charged with lying to investigators amid a criminal fraud probe into his employer, Hi-Tech Pharmaceuticals Inc., but would allow the company to continue footing his legal bills as he seeks new counsel.

  • October 01, 2025

    Cozen O'Connor Adds Healthcare Litigator To Philly Office

    An attorney with more than three decades of experience representing healthcare providers in litigation matters has recently moved his practice to Cozen O'Connor's Philadelphia shop.

  • October 01, 2025

    Weil, Morgan Lewis Steer Up To $900M Biopharma Purchase

    Biopharmaceutical company Halozyme Therapeutics Inc., led by Weil Gotshal & Manges LLP, on Wednesday announced plans to buy fellow biopharma company Elektrofi Inc., advised by Morgan Lewis & Bockius LLP, for up to $900 million.

  • October 01, 2025

    Ga. Panel Backs Doctors In Brothers' Suit Over Mom's Death

    A Georgia appeals panel has sided with a pair of doctors and their employers in a suit by brothers alleging a failure to quickly diagnose their mother before she was paralyzed, saying the trial court did not incorrectly instruct the jury on the definition or application of gross negligence.

Expert Analysis

  • Psychedelic Treatment Regs May Be At A Tipping Point

    Author Photo

    Recent scientific and public attention suggest that development of psychedelics as treatment for some conditions may be at a tipping point, which could bring on more rapid change and opportunities for stakeholders who may in the future benefit from greater access to safe and effective psychedelic medicines, say attorneys at King & Spalding.

  • Series

    Performing As A Clown Makes Me A Better Lawyer

    Author Photo

    To say that being a clown in the Macy’s Thanksgiving Day Parade has changed my legal career would truly be an understatement — by creating an opening to converse on a unique topic, it has allowed me to connect with clients, counsel and even judges on a deeper level, says Charles Tatelbaum at Tripp Scott.

  • Focusing On Fluoride: From FDA To Class Action

    Author Photo

    A class action filed two days after the U.S. Food and Drug Administration announced plans to remove ingestible fluoride prescription drug products for children from the market may be the tip of the iceberg in terms of the connection between government pronouncements on safety and their immediate use as evidence in lawsuits, says Rachel Turow at Skadden.

  • Series

    Law School's Missed Lessons: Rejecting Biz Dev Myths

    Author Photo

    Law schools don’t spend sufficient time dispelling certain myths that prevent young lawyers from exploring new business opportunities, but by dismissing these misguided beliefs, even an introverted first-year associate with a small network of contacts can find long-term success, says Ronald Levine at Herrick Feinstein.

  • Move Beyond Surface-Level Edits To Master Legal Writing

    Author Photo

    Recent instances in which attorneys filed briefs containing artificial intelligence hallucinations offer a stark reminder that effective revision isn’t just about superficial details like grammar — it requires attorneys to critically engage with their writing and analyze their rhetorical choices, says Ivy Grey at WordRake.

  • How Ore. Law Puts New Confines On Corp. Health Ownership

    Author Photo

    A newly enacted law in Oregon strengthens the state’s restrictions on corporate ownership of healthcare practices, with new limitations on overlapping control, permissible services, restrictive covenants and more making it necessary for practices to review decades-old physician practice arrangements, say attorneys at Ropes & Gray.

  • Handling Revenue Cycle Management Disputes In The AI Age

    Author Photo

    As healthcare providers and revenue cycle management vendors face an increasing use of artificial intelligence in claims adjudication, it's important for providers and their general counsel to plan in advance for potential disagreements with vendors and investigate the root causes behind any underperformance that arises, say consultants at AlixPartners.

  • 9th Circ. Has Muddied Waters Of Article III Pleading Standard

    Author Photo

    District courts in the Ninth Circuit continue to apply a defunct and especially forgiving pleading standard to questions of Article III standing, and the circuit court itself has only perpetuated this confusion — making it an attractive forum for disputes that have no rightful place in federal court, say attorneys at Gibson Dunn.

  • Trump Antitrust Shift Eases Pressure On Private Equity Deals

    Author Photo

    Enforcement actions and statements by Trump administration antitrust officials forecast a shift away from specifically targeting private equity activity, which should be welcome news to dealmakers, but firms shouldn't expect to escape traditional antitrust scrutiny, says Nathaniel Bronstein at Fried Frank.

  • Series

    Competing In Modern Pentathlon Makes Me A Better Lawyer

    Author Photo

    Opening myself up to new experiences through competing in modern Olympic pentathlon has shrunk the appearance of my daily work annoyances and helps me improve my patience, manage crises better and remember that acquiring new skills requires working through your early mistakes, says attorney Mary Zoldak.

  • Prepare For Increased FDA Inspections Of Foreign Facilities

    Author Photo

    In light of the U.S. Food and Drug Administration's recently announced plans to expand use of unannounced inspections of foreign drug manufacturing factories, foreign firms should implement best practices in anticipation of an imminent increase in enforcement activity, say attorneys at McGuireWoods.

  • Series

    Law School's Missed Lessons: Teaching Yourself Legal Tech

    Author Photo

    New graduates often enter practice unfamiliar with even basic professional software, but budding lawyers can use on-the-job opportunities to both catch up on technological skills and explore the advanced legal and artificial intelligence tools that will open doors, says Alyssa Sones at Sheppard Mullin.

  • Opinion

    Legacy Of 3 Justices Should Guide Transgender Rights Ruling

    Author Photo

    Three Republican-appointed U.S. Supreme Court justices — Anthony Kennedy, Sandra Day O'Connor and David Souter — gave rise to a jurisprudence of personal liberty that courts today invoke to protect gender-affirming care, and with the court now poised to decide U.S. v. Skrmetti, it must follow the path that they set, says Greg Fosheim at McDermott.

  • How AI May Reshape The Future Of Adjudication

    Author Photo

    As discussed at a recent panel at Texas A&M, artificial intelligence will not erase the human element of adjudication in the next 10 to 20 years, but it will drive efficiencies that spur private arbiters to experiment, lead public courts to evolve and force attorneys to adapt, says Christopher Seck at Squire Patton.

  • When Legal Advocacy Crosses The Line Into Incivility

    Author Photo

    As judges issue sanctions for courtroom incivility, and state bars advance formal discipline rules, trial lawyers must understand that the difference between zealous advocacy and unprofessionalism is not just a matter of tone; it's a marker of skill, credibility and potentially disciplinary exposure, says Nate Sabri at Perkins Coie.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.